PT-141 (Bremelanotide)

PT-141, also known as Bremelanotide, is a breakthrough peptide therapy that has been researched to enhance sexual arousal and desire in both men and women by acting directly on the central nervous system.

Unlike traditional hormone-based treatments, PT-141 works through the melanocortin receptors in the brain to activate natural arousal pathways—which could offer a safer, more effective, and non-hormonal option for patients seeking improved sexual health and emotional well-being.

• Enhanced Sexual Desire and Arousal: Stimulates natural libido in both men and women through central nervous system activation.
• Improved Performance and Satisfaction: Promotes stronger sexual response and increased sensitivity for a more fulfilling experience.
• Effective for Both Genders: Clinically shown to improve sexual arousal disorders in women and support erectile function in men.
• Non-Hormonal: Works independently of sex hormones, offering an alternative for patients who cannot tolerate or prefer to avoid hormonal therapy.
• Emotional and Psychological Benefits: May enhance mood, confidence, and emotional connection by reducing stress and improving overall well-being.